Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI-Sparing Regimens for Initial Treatment of HIV Infection
NCT00013520Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing ABC/3TC/ZDV/EFV, ABC/3TC/ZDV and 3TC/ZDV/EFV (3 arms). Primary endpoint: Virologic Failure at 4 years. Status: completed.
02
Drugs
abacavirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00013520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00013520.